Modulation of NF-κB/miR-21/PTEN Pathway Sensitizes Non-Small Cell Lung Cancer to Cisplatin

Open Access

Peer-reviewed

Research Article

Zhenhua Yang,

Affiliation Department of Respiratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
⨯
Surong Fang,

Affiliation Department of Respiratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
⨯
Yicheng Di,

Affiliation Department of Respiratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
⨯
Weiwei Ying,

Affiliation Department of Respiratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
⨯
Yan Tan,

Affiliation Department of Respiratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
⨯
Wei Gu

* E-mail: njguwei@163.com

Affiliation Department of Respiratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
⨯

Reader Comments (0)

Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Transcription factors
Is the Subject Area "Transcription factors" applicable to this article?

Thanks for your feedback.
Luciferase
Is the Subject Area "Luciferase" applicable to this article?

Thanks for your feedback.
Polymerase chain reaction
Is the Subject Area "Polymerase chain reaction" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Vector cloning
Is the Subject Area "Vector cloning" applicable to this article?

Thanks for your feedback.
Hyperexpression techniques
Is the Subject Area "Hyperexpression techniques" applicable to this article?

Thanks for your feedback.
MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.